Difference between revisions of "C1q"

From Aging Chart
Jump to: navigation, search
(Autoloading by CXLParser)
(Autoloading by CXLParser)
Line 115: Line 115:
 
(.//.)<html><!--Pop-up for: Increased C1q level in serum with age !Pop-up-->
 
(.//.)<html><!--Pop-up for: Increased C1q level in serum with age !Pop-up-->
 
<div class="1KSXRB59D-65MSDN-3J8" style="display:none;">
 
<div class="1KSXRB59D-65MSDN-3J8" style="display:none;">
 +
  
  
Line 122: Line 123:
  
 
<h3>Increased C1q level in serum with age</h3>
 
<h3>Increased C1q level in serum with age</h3>
<div class="links"> </div>
+
<div class="links"><a href="http://www.ncbi.nlm.nih.gov/pubmed/700781">PMID: 700781</a><br /></div>
 
</div>(...)<!--Pop-up for: Antigen !Pop-up-->
 
</div>(...)<!--Pop-up for: Antigen !Pop-up-->
 
<div class="1NCFV3NJK-VS00R5-2240" style="display:none;">
 
<div class="1NCFV3NJK-VS00R5-2240" style="display:none;">
 +
  
  
Line 132: Line 134:
  
 
<h3>Antigen</h3>
 
<h3>Antigen</h3>
<div class="links"> </div>
+
<div class="links"><a href=" ">Antigen</a><br /></div>
 
</div>(...)<!--Pop-up for: Attack protein complex Of complement system !Pop-up-->
 
</div>(...)<!--Pop-up for: Attack protein complex Of complement system !Pop-up-->
 
<div class="1KSXR4GNX-15237TF-2ZZ" style="display:none;">
 
<div class="1KSXR4GNX-15237TF-2ZZ" style="display:none;">
 +
  
  
Line 142: Line 145:
  
 
<h3>Attack protein complex Of complement system</h3>
 
<h3>Attack protein complex Of complement system</h3>
<div class="links"> </div>
+
<div class="links"><a href=" ">Attack protein complex Of complement system</a><br /></div>
 
</div>(...)<!--Pop-up for: Antigen-antibody complex !Pop-up-->
 
</div>(...)<!--Pop-up for: Antigen-antibody complex !Pop-up-->
 
<div class="1NCFVFGKQ-2BVM162-227Z" style="display:none;">
 
<div class="1NCFVFGKQ-2BVM162-227Z" style="display:none;">
 +
  
  
Line 152: Line 156:
  
 
<h3>Antigen-antibody complex</h3>
 
<h3>Antigen-antibody complex</h3>
<div class="links"> </div>
+
<div class="links"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16906756">PMID: 16906756</a><br /></div>
 
</div>(...)<!--Pop-up for: Disturbance of skeletal muscle regenerative ability !Pop-up-->
 
</div>(...)<!--Pop-up for: Disturbance of skeletal muscle regenerative ability !Pop-up-->
 
<div class="1KSXRGP78-257KWRQ-3WD" style="display:none;">
 
<div class="1KSXRGP78-257KWRQ-3WD" style="display:none;">
 +
  
  
Line 162: Line 167:
  
 
<h3>Disturbance of skeletal muscle regenerative ability</h3>
 
<h3>Disturbance of skeletal muscle regenerative ability</h3>
<div class="links"> </div>
+
<div class="links"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17690295">PMID: 17690295</a><br /></div>
 
</div>(...)<!--Pop-up for: Wnt receptor  LRP6  !Pop-up-->
 
</div>(...)<!--Pop-up for: Wnt receptor  LRP6  !Pop-up-->
 
<div class="1KSXRCM8B-28QSHVG-3N9" style="display:none;">
 
<div class="1KSXRCM8B-28QSHVG-3N9" style="display:none;">
 +
  
  
Line 172: Line 178:
  
 
<h3>Wnt receptor  LRP6 </h3>
 
<h3>Wnt receptor  LRP6 </h3>
<div class="links"> </div>
+
<div class="links"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23245947">PMID: 23245947</a><br /></div>
 
</div>(...)<!--Pop-up for: Canonical Wnt signaling !Pop-up-->
 
</div>(...)<!--Pop-up for: Canonical Wnt signaling !Pop-up-->
 
<div class="1KSXRFW2T-1QHN9NL-3SR" style="display:none;">
 
<div class="1KSXRFW2T-1QHN9NL-3SR" style="display:none;">
 +
  
  
Line 182: Line 189:
  
 
<h3>Canonical Wnt signaling</h3>
 
<h3>Canonical Wnt signaling</h3>
<div class="links"> </div>
+
<div class="links"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22682250">PMID: 22682250</a><br /></div>
 
</div>(...)<!--Pop-up for: IgM !Pop-up-->
 
</div>(...)<!--Pop-up for: IgM !Pop-up-->
 
<div class="1NCFV4DZ1-SF6KW5-225W" style="display:none;">
 
<div class="1NCFV4DZ1-SF6KW5-225W" style="display:none;">
 +
  
  
Line 192: Line 200:
  
 
<h3>IgM</h3>
 
<h3>IgM</h3>
<div class="links"> </div>
+
<div class="links"><a href="http://www.ncbi.nlm.nih.gov/pubmed/3385360">PMID: 3385360</a><br /></div>
 
</div>(...)<!--Pop-up for: IgG !Pop-up-->
 
</div>(...)<!--Pop-up for: IgG !Pop-up-->
 
<div class="1NCFV3XND-T474YG-225H" style="display:none;">
 
<div class="1NCFV3XND-T474YG-225H" style="display:none;">
 +
  
  
Line 202: Line 211:
  
 
<h3>IgG</h3>
 
<h3>IgG</h3>
<div class="links"> </div>
+
<div class="links"><a href="http://www.ncbi.nlm.nih.gov/pubmed/6966763">PMID: 6966763</a><br /></div>
 
</div>(...)<!--Pop-up for: Pathogen lysis !Pop-up-->
 
</div>(...)<!--Pop-up for: Pathogen lysis !Pop-up-->
 
<div class="1KSXR7RS1-1SG8HGW-3FX" style="display:none;">
 
<div class="1KSXR7RS1-1SG8HGW-3FX" style="display:none;">
 +
  
  
Line 212: Line 222:
  
 
<h3>Pathogen lysis</h3>
 
<h3>Pathogen lysis</h3>
<div class="links"> </div>
+
<div class="links"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19388159">PMID: 19388159</a><br /></div>
 
</div>(...)<!--Pop-up for: Macrophages !Pop-up-->
 
</div>(...)<!--Pop-up for: Macrophages !Pop-up-->
 
<div class="1KSXRMCT0-22RF5NK-3ZT" style="display:none;">
 
<div class="1KSXRMCT0-22RF5NK-3ZT" style="display:none;">
 +
  
  
Line 222: Line 233:
  
 
<h3>Macrophages</h3>
 
<h3>Macrophages</h3>
<div class="links"> </div>
+
<div class="links"><a href=" ">Macrophages</a><br /></div>
 
</div>(...)<!--Pop-up for: Complement  System protein C1q  !Pop-up-->
 
</div>(...)<!--Pop-up for: Complement  System protein C1q  !Pop-up-->
 
<div class="1KSXQXRP1-87HCBJ-2SN" style="display:none;">
 
<div class="1KSXQXRP1-87HCBJ-2SN" style="display:none;">
 +
  
  
Line 232: Line 244:
  
 
<h3>Complement  System protein C1q </h3>
 
<h3>Complement  System protein C1q </h3>
<div class="links"> </div>
+
<div class="links"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25191325">PMID: 25191325</a><br /><a href="http://www.ncbi.nlm.nih.gov/pubmed/19006321">PMID: 19006321</a><br /></div>
</div>(.//.)(.//.)<!-- Do not edit!  -->
+
</div>(.//.)<h1>C1q</h1>
 +
 
 +
<p>The complement system was first identified as a heat-sensitive factor in fresh serum that ‘complemented’ the effects of specific antibody in the lysis of bacteria and red blood cells.The serum complement system, which represents a chief component of innate immunity, not only participates in inflammation but also acts to enhance the adaptive immune response. Specific activation of complement via innate recognition proteins or secreted antibody releases cleavage products that interact with a wide range of cell surface receptors found on myeloid, lymphoid and stromal cells. This intricate interaction among complement activation products and cell surface receptors provides a basis for the regulation of both B and T cell responses.</p>
 +
<p>Complement C1q is an activator of Wnt signaling. C1q activates canonical Wnt signaling by binding to Fz receptors and subsequently inducing C1s-dependent cleavage of the ectodomain of LRP6. Serum C1q concentration and the expression of C1q in various tissues are increased with aging, which are associated with increased Wnt signaling activity in serum and in multiple tissues during aging.</p>
 +
<p>Wnt signaling plays critical roles in development of various organs and pathogenesis of many diseases, and augmented Wnt signaling has recently been implicated in mammalian aging and aging-related phenotypes. Recent studies have revealed a role of Wnt signaling in the regulation of mammalian aging. Wnt/b-catenin signaling is augmented in a mouse model of accelerated aging, and inhibition of canonical Wnt signaling reverses the aging-associated impairment of skeletal muscle regeneration. Moreover, this age-related activation of Wnt signaling was attributed to the substance(s) in the serum that binds to the extracellular cysteine-rich domain (CRD) of Fz. However, because Wnt proteins tightly bind to the cell surface and/or extracellular matrix and are thought to act in a short-range manner, the substance(s) in the serum that activates Wnt signaling was assumed to be distinct from classical Wnt proteins.</p>
 +
(.//.)<!-- Do not edit!  -->
 
<html>
 
<html>
 
<link type="text/css" rel="stylesheet" href="/aging-chart/js/jquery.qtip.min.css" />
 
<link type="text/css" rel="stylesheet" href="/aging-chart/js/jquery.qtip.min.css" />

Revision as of 14:16, 17 June 2015

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

C1q

The complement system was first identified as a heat-sensitive factor in fresh serum that ‘complemented’ the effects of specific antibody in the lysis of bacteria and red blood cells.The serum complement system, which represents a chief component of innate immunity, not only participates in inflammation but also acts to enhance the adaptive immune response. Specific activation of complement via innate recognition proteins or secreted antibody releases cleavage products that interact with a wide range of cell surface receptors found on myeloid, lymphoid and stromal cells. This intricate interaction among complement activation products and cell surface receptors provides a basis for the regulation of both B and T cell responses.

Complement C1q is an activator of Wnt signaling. C1q activates canonical Wnt signaling by binding to Fz receptors and subsequently inducing C1s-dependent cleavage of the ectodomain of LRP6. Serum C1q concentration and the expression of C1q in various tissues are increased with aging, which are associated with increased Wnt signaling activity in serum and in multiple tissues during aging.

Wnt signaling plays critical roles in development of various organs and pathogenesis of many diseases, and augmented Wnt signaling has recently been implicated in mammalian aging and aging-related phenotypes. Recent studies have revealed a role of Wnt signaling in the regulation of mammalian aging. Wnt/b-catenin signaling is augmented in a mouse model of accelerated aging, and inhibition of canonical Wnt signaling reverses the aging-associated impairment of skeletal muscle regeneration. Moreover, this age-related activation of Wnt signaling was attributed to the substance(s) in the serum that binds to the extracellular cysteine-rich domain (CRD) of Fz. However, because Wnt proteins tightly bind to the cell surface and/or extracellular matrix and are thought to act in a short-range manner, the substance(s) in the serum that activates Wnt signaling was assumed to be distinct from classical Wnt proteins.